JNE Partners’s Orion Biotech Opportunities Corp. Units ORIAU Stock Holding History

JNE Partners’s Portfolio ORIAU Stock Details ORIAU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,500,000	Closed	-$14.6M	–	6
2023 Q1	$14.6M	Hold	1,500,000	–	–	11.07%	3
2022 Q4	$14.7M	Hold	1,500,000	–	–	10.14%	4
2022 Q3	$14.8M	Hold	1,500,000	–	–	8.55%	5
2022 Q2	$14.8M	Hold	1,500,000	–	–	9.64%	4
2022 Q1	$14.7M	Hold	1,500,000	–	–	6.94%	7
2021 Q4	$14.8M	Hold	1,500,000	–	–	9.69%	5
2021 Q3	$14.9M	Hold	1,500,000	–	–	8.37%	6
2021 Q2	$15.1M	Buy	+1,500,000	New	+$15.1M	11.06%	5

JNE Partners's ORIAU Position: Q2 2023 in Review

JNE Partners sold out of Orion Biotech Opportunities Corp. Units (ORIAU) in Q2 2023, closing a stake of 1,500,000 shares — an estimated $14.6M sold.

JNE Partners first reported a position in ORIAU in Q2 2021 and held it in 8 quarters. The position peaked at $15.1M in Q2 2021. 0 funds tracked by Wall St. Rank hold ORIAU as of Q2 2023.

JNE Partners reported no remaining Orion Biotech Opportunities Corp. Units position as of Q2 2023 after selling out during the quarter.
JNE Partners sold 1,500,000 Orion Biotech Opportunities Corp. Units shares in Q2 2023, an estimated $14.6M.
JNE Partners first reported a position in Orion Biotech Opportunities Corp. Units in Q2 2021 and held it in 8 quarters.
JNE Partners's Orion Biotech Opportunities Corp. Units position peaked at $15.1M in Q2 2021.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Units as of Q2 2023.

Based on JNE Partners's 13F filing for Q2 2023, filed 14 Aug 2023.